E. Staffeldt
Impact in
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in ⓘ
-
- Amino Acid Enzymes and Metabolism 5
-
- Cancer, Hypoxia, and Metabolism 5
- Carcinogens and Genotoxicity Assessment 4
- Co-authors
- Carl Peraino (12 shared papers)Richard Fry (14 shared papers)George A. Sacher (4 shared papers)John P. Christopher (2 shared papers)Bruce A. Carnes (2 shared papers)S. D. Vesselinovitch (1 shared paper)Fred J. Stevens (2 shared papers)David A. Haugen (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (3 papers)Toxicological Sciences (1 paper)The American Naturalist (1 paper)Environment International (1 paper)Radiation Research (1 paper)
- Partner nations
- United States
In The Last Decade
E. Staffeldt
23 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 560
- Pharmacology 275
- Biochemistry 154
- Hepatology 109
- Oncology 348
Countries citing papers authored by E. Staffeldt
This map shows the geographic impact of E. Staffeldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Staffeldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Staffeldt more than expected).
Fields of papers citing papers by E. Staffeldt
This network shows the impact of papers produced by E. Staffeldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Staffeldt. The network helps show where E. Staffeldt may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Staffeldt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. | 1971 | 332 |
| 2 | 1974 | 311 | |
| 3 | Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. | 1975 | 209 |
| 4 | Effects of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. | 1973 | 159 |
| 5 | 1977 | 125 | |
| 6 | Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. | 1984 | 106 |
| 7 | 1973 | 104 | |
| 8 | Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. | 1980 | 86 |
| 9 | 1981 | 78 | |
| 10 | 1964 | 52 | |
| 11 | Effects of varying the onset and duration of exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. | 1977 | 49 |
| 12 | Effects of rat strain, diet composition, and phenobarbital on hepatic gamma-glutamyl transpeptidase histochemistry and on the induction of altered hepatocyte foci and hepatic tumors by diethylnitrosamine. | 1987 | 28 |
| 13 | 1963 | 21 | |
| 14 | 1978 | 15 | |
| 15 | Comparative developmental and phenotypic properties of altered hepatocyte foci and hepatic tumors in rats. | 1988 | 13 |
| 16 | 1979 | 10 | |
| 17 | 1978 | 9 | |
| 18 | Studies on the multistage nature of radiation carcinogenesis. | 1982 | 8 |
| 19 | 1969 | 7 | |
| 20 | Comparative effects of aminotriazole on normal and acatalasemic mice. | 1978 | 3 |
About E. Staffeldt
E. Staffeldt is a scholar working on Biochemistry, Cancer Research, Aging, Physiology and Oral Surgery, having authored 25 papers that have together received 1.7k indexed citations. Recurring topics across this work include Diet and metabolism studies (6 papers), Amino Acid Enzymes and Metabolism (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Carcinogens and Genotoxicity Assessment (4 papers), Physiological and biochemical adaptations (2 papers), Effects of Radiation Exposure (2 papers), Animal Nutrition and Physiology (1 paper) and Diet, Metabolism, and Disease (1 paper). The work is most often cited by research in Cancer Research (560 citations), Pharmacology (275 citations), Biochemistry (154 citations), Hepatology (109 citations) and Oncology (348 citations). E. Staffeldt has collaborated with scholars based in United States. Frequent co-authors include Carl Peraino, Richard Fry, George A. Sacher, John P. Christopher, Bruce A. Carnes, S. D. Vesselinovitch, Fred J. Stevens, David A. Haugen, Louise S. Lombard and Anthony Sallese. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Toxicological Sciences, The American Naturalist, Environment International and Radiation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.